Kidney Health Initiative (KHI)

Sixth Annual KHI Stakeholders Meeting

Monday, May 14 – Tuesday, May 15, 2018 | Doubletree by Hilton, Silver Spring, Maryland

"Patients at the Center"
May 14, 2018
3:30 PMRegistration Opens
4:00 PM – 4:15 PM

Welcome and Opening Remarks
Prabir Roy-Chaudhury, MD, PhD, FASN – Co-Chair of the KHI Board of Directors
Paul Conway – Co-Chair of the KHI Program Planning Committee and KHI Board of Directors Member

4:15 PM – 4:45 PM

Opening Session
Moderator: Paul Conway and Prabir Roy-Chaudhury

FDA Perspectives for the Kidney Health Initiative
Janet Woodcock, MD
Director, Center for Drug Evaluation and Research (CDER)
US Food and Drug Administration (FDA)

KidneyX: HHS' Vision for Accelerating Innovation for People with Kidney Diseases
Bruce Greenstein
Chief Technology Officer, Immediate Office of the Secretary
US Department of Health and Human Services (HHS)

Patient Perspective
Pamela Duquette
KHI Patient and Family Partnership Council

Panel and Audience Discussion

5:45 PM – 7:30 PM

Working Dinner: KHI Project Status and Lessons Learned

Development of a Roadmap for Innovations in Renal Replacement Therapy (RRT)

Prioritizing Symptoms of ESRD Patients for Developing Therapeutic Interventions

Innovations in Fluid Management

Panel and Audience Discussion

7:30 PM – 8:30 PMNetworking and Dessert Reception


May 15, 2018
7:30 AM – 8:00 AMBreakfast/New Member Orientation
8:00 AM – 8:15 AM

Opening Comments
Katherine R. Tuttle, MD, FASN - Co-Chair of the KHI Program Planning Committee and KHI Board of Directors Member

8:15 AM – 9:30 AM

Patients at the Center of Innovation and Implementation of Care in Diabetic Kidney Disease
Moderator: Krishna Polu, MD

Learning Lessons from Precision Medicine: An Update from Innovative Medicine Initiative's (IMI) BEAt-DKD
Maria F. Gomez, PhD
Lund University Diabetes Centre, Sweden

Once We Know, How Do We Get the Job Done?
Jamie A. Green, MD, MS
Geisinger Medical Center

Patient Entrepreneurs: Influencing the Development of Products that Matter Most to Patients
Karin Hehenberger, MD, PhD
Type 1 Diabetic and Kidney Transplant Recipient
Founder, Lyfebulb

Panel and Audience Discussion

9:30 AM – 10:15 AMBreakout I: Discussion of Project Proposals
10:15 AM – 10:30 AMCoffee Break
10:30 AM – 11:15 AMBreakout II: Discussion of Project Proposals
11:15 AM – 12:30 PM

KHI Project Status and Lessons Learned

Identification of Appropriate Endpoints for Clinical Trials in Hyperoxaluria

Identifying Surrogate Endpoints for Clinical Trials in IgA Nephropathy

Surrogate Endpoints in FSGS

Overcoming Barriers to Drug Development in Children with CKD

Understanding and Overcoming the Challenges to Involving Patients with Kidney Disease in Cardiovascular Trials

Panel and Audience Discussion

12:30 PM – 1:00 PMNetworking Lunch
1:00 PM – 2:15 PM

Making Progress in the Treatment of Kidney Disease
Moderator: Kevin Fowler

Innovations to Accelerate Therapeutic Development
Barbara S. Gillespie, MD, MMS, FASN
Covance CRO and University of North Carolina

New Thinking and Approaches to Kidney Replacement
Jonathan Himmelfarb, MD, FASN
Kidney Research Institute and Center for Dialysis Innovation

Patient Perspective
Vanessa Evans, MA
Patient Advocate Manager, NxStage Medical

Panel and Audience Discussion
Dr. Himmelfarb, Dr. Gillespie, and Ms. Evans

2:15 PM – 2:30 PM

Closing Remarks
Dr. Roy-Chaudhury, Dr. Tuttle, and Mr. Conway



Past Meetings